Sign in

    Justin Wang • Morgan Stanley

    Justin Wang's questions to STERIS plc (STE) leadership

    Justin Wang's questions to STERIS plc (STE) leadership • Q1 2026

    Question

    Justin Wang of Morgan Stanley asked why STERIS's ethylene oxide (EO) facilities were not granted regulatory relief from NESHAP compliance and how this development affects the competitive environment.

    Answer

    Daniel Carestio, President & CEO, stated that STERIS did not apply for the two-year extension because it is not needed. He explained that the company has been proactively upgrading its facilities for four years and is confident in its ability to meet compliance deadlines. He views the relief for competitors as not materially impacting the competitive landscape.

    Ask Fintool Equity Research AI

    Justin Wang's questions to Transmedics Group Inc (TMDX) leadership

    Justin Wang's questions to Transmedics Group Inc (TMDX) leadership • Q2 2025

    Question

    Justin Wang, on for Patrick, asked for early surgeon feedback on the NOP Access platform and how it integrates with the broader NOP ecosystem.

    Answer

    CEO Waleed Hassanein described early user feedback on NOP Access as "off the chart." He clarified that NOP Access is the customer-facing portal of a single, seamless digital ecosystem that includes the NOP Connect back-end and integrated logistics and mapping functions.

    Ask Fintool Equity Research AI